[1]
Afreen Munir et al. 2024. ASSOCIATION OF RENAL SAFETY PROFILE AND IMPACT OF ALBUMIN-TO-CREATININE RATIO OF DPP4 INHIBITORS COMPARED TO SULFONYLUREA IN DIABETIC KIDNEY DISEASE. The Bioscan. 19, 3 (Nov. 2024), 28–32. DOI:https://doi.org/10.63001/tbs.2024.v19.i03.pp28-32.